search

Active clinical trials for "Non-alcoholic Fatty Liver Disease"

Results 1131-1140 of 1204

Non-invasive Biomarkers of Metabolic Liver Disease (NIMBLE) Study 1.2

Nonalcoholic Fatty Liver

This study is a prospective, observational, single-center, short-term cross-sectional study to assess the repeatability and reproducibility of a set of specified MRI quantitative biomarkers.

Completed18 enrollment criteria

Ultrasound Quantification of Liver Fat

Non-Alcoholic Fatty Liver Disease

The investigators plan a prospective study designed to evaluate the accuracy of a new ultrasound method for quantification of liver fat content.

Completed7 enrollment criteria

The Role of Immune Semaphorins in NAFLD

Non-Alcoholic Fatty Liver DiseaseImmune Response3 more

To goal is to identify semaphorins that are associated with NAFLD and to investigate their relationship with variable degrees of steatosis and fibrosis.

Completed9 enrollment criteria

Barriers to MASLD Management in Europe: Findings From a Multidisciplinary HCP-survey

Non-alcoholic Steatohepatitis (MASH)Non-alcoholic Fatty Liver Disease (MASLD)

The purpose of this study is to better understand the main barriers to earlier diagnosis and better management of MASLD/MASH patients and to understand the key barriers to adoption of guidelines. This study is a cross-sectional design, conducted across 5 countries in Europe- France, Germany, Spain, United Kingdom (UK), Italy. Study participants, Hepatologists and other metabolically focused healthcare providers (HCPs), will be recruited to complete a 15 minute self-administered online survey.

Completed17 enrollment criteria

Assessing Kids for Liver Inflammation and Fibrosis Using Non-invasive MRI

Non-alcoholic SteatohepatitisLiver Diseases3 more

This is a prospective observational study which will recruit up to 100 paediatric participants over a period of 30 months to determine whether MRI is as accurate at detecting, distinguishing, and monitoring liver disease as current standard of care techniques such as liver biopsy and fibroscan.

Completed17 enrollment criteria

Dietary Determinants in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)

Dietary IntakeNAFLD

Patients with NAFLD and matched controls will be asked about their demographic status, and their previous year dietary intakes using a validated FFQ.

Completed3 enrollment criteria

Seum Bile Acid Profile in Type 2 Diabetes and Association Between Bile Cid Profile and Adipokine...

Type 2 DiabetesPrediabetes2 more

"The goal of this work is to critically test the hypothesis that there exists a different profile of bile acids (BAs) in patient with type 2 diabetes mellitus (T2DM) compared with normal controls. Through confirmation of different profile of BAs in T2DM, investigator will suggest modulation of specific bile acids as a new possible treatment target in patients with T2DM. Investigator also expect the specific BAs signature will be used to screen T2DM before hyperglycemia. In addition, investigator will evaluate the association between each BA species and serum total glucagon like peptide-1 (GLP-1) or fibroblast growth factor-19 (FGF-19) concentrations to determine if the specific BAs profile is related with total GLP-1 or FGF-19 concentration in serum. Investigatr also evaluates the correlation between each BA species and metabolic profiles and oxidative stress marker to find possible roles of each BA component in glucose metabolism.

Completed7 enrollment criteria

Study of the Association of Nonalcoholic Fatty Liver Disease With Colorectal Malignant Neoplasm...

Colorectal NeoplasmsNonalcoholic Fatty Liver Disease

The aim of this sudy is to investigate the prevalence of colorectal cancer (CRC) in patients with nonalcoholic fatty liver disease (NAFLD) and evaluate whether NAFLD is a risk factor for CRC.

Completed5 enrollment criteria

A Case Control Study Evaluating the Prevalence of Non-Alcoholic Fatty Liver Disease Among Patients...

PsoriasisNonalcoholic Fatty Liver Disease

Main objectives 1. Establish the association of psoriasis and the presence of NAFLD in the patients with psoriasis attending dermatologic clinic center. Secondary objective Evaluate for the presence of other components metabolic syndrome in this group of patients including hypercholesterolemia, hypertension, obesity, and insulin resistance Determine if there is an association between the extent and severity of psoriasis and the presence of NAFLD. Identify an association between BMI and presence of NAFLD in people with psoriasis and use it as a predictive index for primary screening of NAFLD in psoriatic patients.

Completed7 enrollment criteria

Meta-analyses of the Effect of Important Food Sources of Sugars on Cardiometabolic Risk Factors...

DyslipidemiaDiabetes6 more

Fructose-containing sugars have been implicated in the epidemics of obesity, diabetes and related cardiometabolic disorders. This view is supported by lower quality evidence from ecological observations, animal models, and select human trials. Higher level evidence from controlled trials and prospective cohort studies have been inconclusive. Whether sugars contribute to cardiometabolic complications independent of their calories remains unclear. To address the uncertainties, the investigators propose to conduct a series of systematic reviews and meta-analyses of the totality of the evidence from controlled trials to distinguish the contribution of fructose-containing sugars from that of energy in the development of markers of cardiometabolic risk. The findings generated by this proposed knowledge synthesis will help improve the health of consumers through informing evidence-based guidelines and improving health outcomes by educating healthcare providers and patients, stimulating industry innovation, and guiding future research design.

Unknown status11 enrollment criteria
1...113114115...121

Need Help? Contact our team!


We'll reach out to this number within 24 hrs